FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

410861007: Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3677285011 Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3677286012 Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet est un(e) (attribut) Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) true Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Plays role Antiparkinson therapeutic role true Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet est un(e) (attribut) médicament contenant lévodopa et carbidopa et entacapone false Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Entacapone (substance) false Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Levodopa (substance) false Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Carbidopa false Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a une forme pharmaceutique (attribut) comprimé false Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a une forme pharmaceutique (attribut) Oral tablet true Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet est un(e) (attribut) Product manufactured as oral dose form (product) false Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Levodopa (substance) true Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 50 (qualifier value) false Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Entacapone (substance) false Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Entacapone (substance) false Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 200 (qualifier value) false Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Entacapone (substance) true Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 200 (qualifier value) false Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Carbidopa true Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 12.5 (qualifier value) false Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Levodopa (substance) false Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Levodopa (substance) false Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 50 (qualifier value) false Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet a pour principe actif (attribut) Carbidopa false Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) Carbidopa false Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has presentation strength numerator value (attribute) 12.5 (qualifier value) false Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has precise active ingredient Carbidopa true Inferred relationship Some 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet est un(e) (attribut) Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) false Inferred relationship Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has precise active ingredient Entacapone (substance) true Inferred relationship Some 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has precise active ingredient Levodopa (substance) true Inferred relationship Some 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Count of base of active ingredient trois false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Canada English language reference set (foundation metadata concept)

GB English

US English

Back to Start